Company intelligence / Profile preview

Jiangsu Wangao Pharmaceutical Co., Ltd.

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Jiangsu Wangao Pharmaceutical is an active Chinese pharmaceutical manufacturer focused on small molecule drugs, with a pipeline spanning neoplasms, metabolic/endocrine disorders, nervous system diseases, and urogenital conditions. The company has several clinical-stage assets and is involved in the development and manufacturing of both innovative and generic pharmaceuticals. It recently entered into agreements to transfer rights to certain products such as nintedanib to Gyre Pharmaceuticals.

Therapeutic areas: GastroenterologyCardiovascularOncologyNephrology
Modalities: Small molecule drugs
Industry: Biotech

Drug pipeline

4 assets

pirfenidone

Commercial

Indications: Idiopathic pulmonary fibrosis

3 more assets in the full pipeline.

Partnerships

Gyre Pharmaceuticals—recent agreement regarding nintedanib rights transfer/commercialization in China.

Beyond the preview

Go deeper on Jiangsu Wangao Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Wangao Pharmaceutical Co., Ltd..